Form CORRESP - Correspondence:
SEC Accession No. 0001193125-24-000774
Filing Date
2024-01-02
Accepted
2024-01-02 17:21:52
Documents
3

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 25762
2 GRAPHIC g551455g0102074106798.jpg GRAPHIC 2373
3 GRAPHIC g551455g0102074107405.jpg GRAPHIC 1788
  Complete submission text file 0001193125-24-000774.txt   32793
Mailing Address 400 SPECTRUM CENTER DRIVE SUITE 2040 IRVINE CA 92618
Business Address 400 SPECTRUM CENTER DRIVE SUITE 2040 IRVINE CA 92618 (949) 419-6203
CG Oncology, Inc. (Filer) CIK: 0001991792 (see all company filings)

EIN.: 371611499 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)